Status:
COMPLETED
Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
Lead Sponsor:
Inonu University
Conditions:
Major Depression
Electroconvulsive Therapy
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The aim of this study was to evaluate the effect of sevoflurane or ketamine on the QTc and Tp-e interval during in patients with major depression.
Detailed Description
Patients enrolled in the study are randomly allocated by computer-generated random numbers to receive either sevoflurane or ketamine for their initial ECT session. They subsequently receive an alterna...
Eligibility Criteria
Inclusion
- Unpremedicated
- American Society of Anesthesiologists (ASA) I-II the patients
- Major depressions patients scheduled for ECT sessions
Exclusion
- pregnant
- with permanent pacemakers,
- diabetes mellitus,
- atrial fibrillation,
- electrolyte imbalance,
- patients taking antiarrhythmics and β-blockers.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01870219
Start Date
February 1 2012
End Date
May 1 2013
Last Update
June 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turgut Ozal Medical Center
Malatya, Turkey (Türkiye), 44315